Immunic investor relations
Witryna10 paź 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. Rx Communications … Witryna17 lis 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. US IR Contact Rx Communications Group Melody Carey +1 917 322 2571 [email protected]. US Media Contact KOGS Communication Edna Kaplan +1 781 639 1910 [email protected]
Immunic investor relations
Did you know?
Witryna12 kwi 2024 · For Institutional Investors, Securities Analysts. Phone line:+81-3-3244-3022. Business hours (JST): From Monday to Thursday: 8:45 am to 5:45 pm, Friday: 8:45 am to 4:00 pm (closed on Saturdays, Sundays, national holidays and company holidays) Witryna22 lut 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. US IR Contact Rx Communications Group Paula Schwartz +1 917 633 7790 [email protected]
Witryna3 lis 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. US IR Contact Rx Communications Group Paula Schwartz +1 917 633 7790 [email protected] Witryna3 lis 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. US IR Contact Rx …
Witryna1 kwi 2024 · SAN DIEGO , March 14, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company will present a quantitative systems pharmacology (QSP) model for predicting the effects of the investigational enzyme replacement therapy pegtibatinase, in classical … Witryna8 lut 2024 · Mersana Fourth Quarter 2024 Earnings Call. February 28, 2024 at 8:00 AM EST. Listen to webcast.
Witryna2 dni temu · Telenor ASA appointed Frank Maao as senior vice president for capital markets and investor relations, according to a statement. Maao comes from the …
Witryna29 kwi 2016 · About Immunic. Immunic AG (www.immunic.de) is a start-up biotech company founded in April 2016 and focused on the development of immune modulators to block Th17- and Th1-mediated immune and autoimmune responses. The company’s two development programs include orally available, small molecule inhibitors of … northern lights lower 48Witryna6 lis 2024 · Immunic, Inc. (NASDAQ:NASDAQ:IMUX) Q3 2024 Earnings Conference Call November 3, 2024 8:00 AM ETCompany ParticipantsJessica Breu - Head, IR and … northern lights luggerWitryna3 mar 2024 · We disclaim any obligation to supplement or update the information in these press releases. Year. 2024. March 27, 2024. Incyte Announces Japanese Approval of Pemazyre® (pemigatinib) for the Treatment of Patients with Myeloid/Lymphoid Neoplasms (MLNs) March 23, 2024. Incyte Provides Regulatory Update on Ruxolitinib … how to rotate photo using keyboardWitryna10 paź 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx … northern lights lofoten islands norwayWitrynaM.A. Business Management Student, Investor Relations and PR at Immunic Therapeutics Metropolregion München. 95 Follower:innen … northern lights luggage tagWitryna31 gru 2024 · Results of Operations. The Company reported a net loss of $41.5 million for the year ended December 31, 2024, which compared with a net loss of $52.1 million for the prior year. This resulted in a net loss of $0.98 per share for the year ended December 31, 2024, as compared to a net loss of $1.31 per share for 2024, on both a … northern lights luminairesWitryna14 mar 2024 · Seed-Investment des HTGF: Münchner Startup oculai schließt 2,5 Mio. € Seed-Runde zur KI-gestützten Prozesserfassung auf Baustellen ab ... Parcellab, Cobrainer, Quantum Systems, Casavi, Riskmethods, Tubulis, Catalym, Immunic, Sirion und viele weitere. ... Stefanie Grüter, Partner Communications & Relations T.: +49 … northern lights lugger generator